Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
The positivity of rheumatoid factor and anti-cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection
Rheumatology International, 06/29/09
Orge E et al. – Study demonstrates that cyclic citrullinated peptide (CCP) antibody (a highly specific biomarker for rheumatoid arthritis in the general population) is a more useful test than rheumatoid factor (RF) among patients with chronic hepatitis C virus (HCV) infection without arthritis.
Methods- Aim was to determine whether CCP Ab was useful for the diagnosis of RA in nonarthritic pts with HCV
- Blood samples obtained from:
- 39 pts with chronic HCV infection
- 87 normal sera from volunteer blood donors, and
- 108 blood samples from pts with RA, from the rheumatology clinic
- RF was measured using the Dade-Behring nephelometer
- Abs to CCP were measured with ELISA
- Sensitivity, specificity and positive predictive value of the anti-CCP test was superior to the RF test
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study
Arthritis Research & Therapy, 10/16/09
The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: A prospective study
Arthritis & Rheumatism, 11/04/09
Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research , 11/02/09
Sponsor
Article Search
Sponsor


See Latest Articles


